CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value
$89.79+0.27 (+0.30%)
Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%
Cvs Health total assets
Total assets on the balance sheet at the end of each period.
Cvs Health's total assets was $258.08B at Sep 30, 2026. For fiscal 2025 it was $253.54B, up 0.1% from the year before. Over ten years it grew 10.6% a year on average. The highest annual figure on record is $253.54B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.54B | +0.1% |
| FY2024 | Dec 31, 2024 | $253.22B | +1.4% |
| FY2023 | Dec 31, 2023 | $249.73B | +9.4% |
| FY2022 | Dec 31, 2022 | $228.28B | -2.0% |
| FY2021 | Dec 31, 2021 | $233.00B | +1.0% |
| FY2020 | Dec 31, 2020 | $230.72B | +3.7% |
| FY2019 | Dec 31, 2019 | $222.45B | +13.2% |
| FY2018 | Dec 31, 2018 | $196.46B | +106.5% |
| FY2017 | Dec 31, 2017 | $95.13B | +0.7% |
| FY2016 | Dec 31, 2016 | $94.46B | +2.2% |
| FY2015 | Dec 31, 2015 | $92.44B | +24.6% |
| FY2014 | Dec 31, 2014 | $74.19B | +3.7% |
| FY2013 | Dec 31, 2013 | $71.53B | +8.0% |
| FY2012 | Dec 31, 2012 | $66.22B | +2.1% |
| FY2011 | Dec 31, 2011 | $64.85B | +4.3% |
| FY2010 | Dec 31, 2010 | $62.17B | +0.9% |
| FY2009 | Dec 31, 2009 | $61.64B | +1.1% |
| FY2008 | Dec 31, 2008 | $60.96B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $258.08B | +1.1% |
| Q2 FY2026 | Jun 30, 2026 | $253.77B | -1.8% |
| Q1 FY2026 | Mar 31, 2026 | $252.97B | -1.0% |
| Q4 FY2025 | Dec 31, 2025 | $253.54B | +0.1% |
| Q3 FY2025 | Sep 30, 2025 | $255.33B | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | $258.34B | +2.3% |
| Q1 FY2025 | Mar 31, 2025 | $255.59B | +2.3% |
| Q4 FY2024 | Dec 31, 2024 | $253.22B | +1.4% |
| Q3 FY2024 | Sep 30, 2024 | $252.43B | +0.4% |
| Q2 FY2024 | Jun 30, 2024 | $252.48B | +1.0% |
| Q1 FY2024 | Mar 31, 2024 | $249.74B | +4.4% |
| Q4 FY2023 | Dec 31, 2023 | $249.73B | +9.4% |
| Q3 FY2023 | Sep 30, 2023 | $251.31B | +8.7% |
| Q2 FY2023 | Jun 30, 2023 | $250.07B | +8.6% |
| Q1 FY2023 | Mar 31, 2023 | $239.33B | +2.8% |
| Q4 FY2022 | Dec 31, 2022 | $228.28B | -2.0% |
| Q3 FY2022 | Sep 30, 2022 | $231.21B | -1.6% |
| Q2 FY2022 | Jun 30, 2022 | $230.28B | -0.4% |
| Q1 FY2022 | Mar 31, 2022 | $232.87B | +1.4% |
| Q4 FY2021 | Dec 31, 2021 | $233.00B | +1.0% |
| Q3 FY2021 | Sep 30, 2021 | $234.89B | +0.9% |
| Q2 FY2021 | Jun 30, 2021 | $231.16B | -1.8% |
| Q1 FY2021 | Mar 31, 2021 | $229.61B | -0.4% |
| Q4 FY2020 | Dec 31, 2020 | $230.72B | +3.7% |
| Q3 FY2020 | Sep 30, 2020 | $232.90B | +5.8% |
| Q2 FY2020 | Jun 30, 2020 | $235.50B | +7.6% |
| Q1 FY2020 | Mar 31, 2020 | $230.64B | +4.9% |
| Q4 FY2019 | Dec 31, 2019 | $222.45B | +13.2% |
| Q3 FY2019 | Sep 30, 2019 | $220.11B | +67.4% |
| Q2 FY2019 | Jun 30, 2019 | $218.90B | +64.2% |
| Q1 FY2019 | Mar 31, 2019 | $219.77B | +62.6% |
| Q4 FY2018 | Dec 31, 2018 | $196.46B | +106.5% |
| Q3 FY2018 | Sep 30, 2018 | $131.51B | +41.6% |
| Q2 FY2018 | Jun 30, 2018 | $133.29B | +44.1% |
| Q1 FY2018 | Mar 31, 2018 | $135.14B | +45.8% |
| Q4 FY2017 | Dec 31, 2017 | $95.13B | +0.7% |
| Q3 FY2017 | Sep 30, 2017 | $92.85B | – |
| Q2 FY2017 | Jun 30, 2017 | $92.53B | – |
| Q1 FY2017 | Mar 31, 2017 | $92.67B | – |
| Q4 FY2016 | Dec 31, 2016 | $94.46B | – |
See a number that looks wrong?